Dr Elena Crisà/touchhaematology.com
Oct 19, 2025, 11:27
Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
TMC (Touch Medical Communications) shared a post on LinkedIn:
“Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
In this inspiring interview, Dr Elena Crisà (Candiolo Cancer Institute, Italy) discusses how precision medicine is transforming the diagnosis and treatment of acute myeloid leukaemia ( AML ).
From clinical trials to patient-centred care, Dr Crisà shares what drives her work and why aligning treatment with individual values is essential.”
Read the full feature here.
Stay updated with Hemostasis Today.
-
Jun 5, 2026, 09:58Evaluating Anti-Xa Targets and Outcomes in Arterial Interventions – JTH
-
Jun 5, 2026, 08:27Morten Thaysen Andersen: Platelet Glycobiology and The Importance of FUT8 for Platelet Function
-
Jun 5, 2026, 08:10Michael Ertl: Air Pollution and Stroke – Which Patients Are Particularly at Risk?
-
Jun 5, 2026, 07:58Omid Seidizadeh: Pleasure to Present on VWD in Aging at the ERN-EuroBloodNet Webinar Series
-
Jun 5, 2026, 07:14Elissa Embrechts: A Small But Meaningful Step Towards Better Fall Risk Prediction in Stroke Rehabilitation
-
Jun 5, 2026, 03:27Lovish Garg: Restoring Venous Flow Through Catheter-Directed Thrombus Removal
-
Jun 5, 2026, 03:20Javed Anees: Anemia in Pregnancy Is Common, but Never Trivial
-
Jun 5, 2026, 02:52Andrada Seicean: Endoscopic Ultrasound and Portal Pressure Assessment in Patients Undergoing TIPS
-
Jun 5, 2026, 02:29Sam Tomy K: Antinuclear Antibody Testing and Its Role in Autoimmune Disease Diagnosis